GEVO INC (GEVO)

US3743964062 - Common Stock

0.6837  -0.03 (-3.61%)

After market: 0.6949 +0.01 (+1.64%)

Fundamental Rating

2

GEVO gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 213 industry peers in the Oil, Gas & Consumable Fuels industry. The financial health of GEVO is average, but there are quite some concerns on its profitability. GEVO is valied quite expensively at the moment, while it does show a decent growth rate.



0

1. Profitability

1.1 Basic Checks

In the past year GEVO has reported negative net income.
In the past year GEVO has reported a negative cash flow from operations.
In the past 5 years GEVO always reported negative net income.
GEVO had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

With a Return On Assets value of -10.65%, GEVO is not doing good in the industry: 90.09% of the companies in the same industry are doing better.
The Return On Equity of GEVO (-12.45%) is worse than 84.43% of its industry peers.
Industry RankSector Rank
ROA -10.65%
ROE -12.45%
ROIC N/A
ROA(3y)-11.11%
ROA(5y)-18.09%
ROE(3y)-12.96%
ROE(5y)-21.17%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

With a Gross Margin value of 16.67%, GEVO is not doing good in the industry: 70.75% of the companies in the same industry are doing better.
The Profit Margin and Operating Margin are not available for GEVO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 16.67%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

4

2. Health

2.1 Basic Checks

GEVO does not have a ROIC to compare to the WACC, probably because it is not profitable.
GEVO has more shares outstanding than it did 1 year ago.
The number of shares outstanding for GEVO has been increased compared to 5 years ago.
The debt/assets ratio for GEVO is higher compared to a year ago.

2.2 Solvency

Based on the Altman-Z score of -0.46, we must say that GEVO is in the distress zone and has some risk of bankruptcy.
GEVO has a worse Altman-Z score (-0.46) than 75.00% of its industry peers.
GEVO has a Debt/Equity ratio of 0.13. This is a healthy value indicating a solid balance between debt and equity.
With a decent Debt to Equity ratio value of 0.13, GEVO is doing good in the industry, outperforming 77.83% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF N/A
Altman-Z -0.46
ROIC/WACCN/A
WACC6.82%

2.3 Liquidity

A Current Ratio of 12.80 indicates that GEVO has no problem at all paying its short term obligations.
GEVO's Current ratio of 12.80 is amongst the best of the industry. GEVO outperforms 96.70% of its industry peers.
A Quick Ratio of 12.62 indicates that GEVO has no problem at all paying its short term obligations.
The Quick ratio of GEVO (12.62) is better than 96.70% of its industry peers.
Industry RankSector Rank
Current Ratio 12.8
Quick Ratio 12.62

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 32.56% over the past year.
The Revenue has grown by 241.96% in the past year. This is a very strong growth!
Measured over the past years, GEVO shows a very negative growth in Revenue. The Revenue has been decreasing by -12.14% on average per year.
EPS 1Y (TTM)32.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-14.29%
Revenue 1Y (TTM)241.96%
Revenue growth 3Y45.88%
Revenue growth 5Y-12.14%
Sales Q2Q%-1.72%

3.2 Future

Based on estimates for the next years, GEVO will show a very strong growth in Earnings Per Share. The EPS will grow by 46.76% on average per year.
GEVO is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 65.72% yearly.
EPS Next Y-22.04%
EPS Next 2Y-7.97%
EPS Next 3Y25.61%
EPS Next 5Y46.76%
Revenue Next Year2.09%
Revenue Next 2Y34.06%
Revenue Next 3Y99.4%
Revenue Next 5Y65.72%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

1

4. Valuation

4.1 Price/Earnings Ratio

GEVO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year GEVO is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as GEVO's earnings are expected to grow with 25.61% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-7.97%
EPS Next 3Y25.61%

0

5. Dividend

5.1 Amount

GEVO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

GEVO INC

NASDAQ:GEVO (5/31/2024, 7:00:00 PM)

After market: 0.6949 +0.01 (+1.64%)

0.6837

-0.03 (-3.61%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap161.51M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -10.65%
ROE -12.45%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 16.67%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 12.8
Quick Ratio 12.62
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)32.56%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y-22.04%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)241.96%
Revenue growth 3Y45.88%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y